Related by context. All words. (Click for frequent words.) 74 hyperplastic 71 gastric carcinoma 71 pre cancerous 71 pulmonary metastases 70 prostate carcinoma 70 neoplastic lesions 69 epithelial tumors 69 precursor lesions 69 invasive carcinoma 69 tumoral 69 colorectal carcinoma 69 neoplastic 69 metachronous 69 osteosarcomas 68 cisplatin resistant 68 squamous cell carcinoma SCC 68 prostate cancer CaP 68 mucinous 68 neoplasm 68 HNSCC 68 endometrial cancers 68 adenocarcinomas 68 granulomatous 68 papillary 68 papillomas 67 cervical lymph nodes 67 leiomyomas 67 adenomatous 67 urothelial carcinoma 67 lichen planus 67 uveal melanoma 67 basal cell carcinoma BCC 67 solar keratosis 67 gastric adenocarcinoma 67 nonmelanoma skin cancers 67 pheochromocytoma 67 malignant transformation 67 premalignant lesions 67 cell carcinomas 67 carcinoids 67 basal cell carcinomas 67 HbF 67 pancreatic adenocarcinoma 67 colorectal tumors 67 Basal cell 67 ovarian carcinoma 67 bacteriuria 67 adenoma 67 neoplasias 67 pleomorphic 67 Barrett esophagus BE 66 endometrial hyperplasia 66 hamartomas 66 eccrine 66 breast carcinoma 66 malignant growths 66 histologic subtype 66 malignant pancreatic 66 Hurthle cell 66 testicular tumors 66 leiomyoma 66 gastric carcinomas 66 adenomatous polyps 66 Papillary 66 situ LCIS 66 bladder cancers 66 lobular carcinoma 66 ductal breast cancer 66 lung carcinomas 66 thyroid nodules 66 myelofibrosis polycythemia vera 66 intestinal metaplasia 66 obstructive coronary 66 carcinoid 66 complement inhibitor eculizumab 66 metaplasia 66 dysplastic lesions caused 65 anaplastic 65 hyperplasia 65 pituitary adenomas 65 ductal 65 biliary tract 65 proximal colon 65 epithelial cancers 65 proto oncogene 65 malignant prostate 65 neoplasia 65 lipomas 65 papillary renal cell carcinoma 65 neurofibromas 65 ADPKD 65 atypical hyperplasia 65 neoplasms 65 Sezary syndrome 65 carcinoid tumor 65 colorectal neoplasms 65 intraductal 65 oncogenic transformation 65 cervical lesions 65 carcinoma 65 Fas ligand 65 malignant ovarian 65 mycosis fungoides 65 p# mutations 65 peritoneal carcinomatosis 65 lung adenocarcinomas 65 Colon polyps 65 seminomas 65 MALT lymphoma 65 precancerous cervical 65 paraganglioma 65 choroidal neovascularization 65 imatinib resistant 65 renal carcinoma 65 gastric cardia 65 Squamous 65 nodal metastasis 65 precancerous condition 65 hepatocellular carcinomas 65 ASCUS 65 ovarian pancreatic 65 micronuclei 65 Sjögren syndrome 65 colorectal adenoma 65 resectable 65 sarcomatoid 65 hematologic disorders 64 apocrine 64 pre cancerous lesion 64 gastrointestinal stromal tumors GISTs 64 kidney urologic 64 meningiomas 64 mammary cancers 64 neovascularisation 64 chronic eosinophilic leukemia 64 adenomatous polyp 64 aplasia 64 Malignant tumors 64 Squamous cell 64 papillary carcinoma 64 ductal carcinomas 64 comedones 64 lung metastasis 64 thyroid carcinoma 64 dysplasias 64 distant metastasis 64 carcinomas 64 hypereosinophilic syndrome 64 serous ovarian cancer 64 ERK signaling 64 infiltrative 64 epithelial ovarian 64 trophoblasts 64 GNAQ 64 solar keratoses 64 BRCA deficient 64 MGUS 64 recurrent glioblastoma multiforme 64 N. gonorrhoeae 64 gastric cancers 64 GISTs 64 histologically 64 cell carcinoma 64 neurofibroma 64 metastatic lesions 64 histological subtype 64 metastatic lymph nodes 64 bronchogenic carcinoma 64 mesenchymal cell 64 choroidal neovascularization CNV 64 PAOD 64 explants 64 liver metastasis 64 mucus glands 64 basal cell nevus syndrome 64 gastric varices 64 esophageal gastric 64 Candida infection 64 renal cell carcinomas 64 epithelioid 64 skeletal metastases 64 NF kappaB activation 64 polypoid 64 prognostic indicator 64 varices 64 HBeAg negative 64 nonproliferative 64 colorectal gastric 64 haematopoietic 64 hepatocellular 64 micrometastases 64 squamous cell cancers 64 nonmelanoma 64 melanocytic 64 urothelial 64 atherosclerotic disease 64 metastatic neuroendocrine tumors 64 ANCA associated 64 Gorlin syndrome 64 underlying vasculopathy 64 hamartoma 64 Upregulation 64 androgen receptor AR 64 motor neuron degeneration 64 chromosomal mutations 64 lymphadenopathy 64 androgen dependent 64 neovascular 64 bullous 64 SSc 64 mucosal lesions 64 oesophageal adenocarcinoma 64 uterine tumors 64 monogenic 64 fibrin deposition 64 nonmelanoma skin cancer 64 atherosclerotic lesions 64 K ras mutations 64 tumor metastasis 64 advanced adenomas 64 localized renal 64 KRAS oncogene 64 pancreatic prostate 63 myeloproliferative disorders 63 molecular abnormalities 63 CYT# potent vascular disrupting 63 normal karyotype 63 dysplastic 63 invasive ductal 63 renal scarring 63 mesotheliomas 63 thymoma 63 metastatic gastric 63 neoplastic cells 63 hypermethylated 63 prostate adenocarcinoma 63 malignancies 63 squamous cell lung cancer 63 breast carcinomas 63 geographic atrophy 63 myeloid 63 Basal Cell 63 Leydig cell 63 cervical carcinoma 63 endometrial carcinoma 63 peritumoral 63 transgene expression 63 prostate carcinomas 63 precancerous 63 spontaneously regress 63 gastrointestinal stromal tumor 63 cervical dysplasia 63 benign moles 63 pancreatic colon 63 heterotaxy 63 phenotypic expression 63 macroalbuminuria 63 ductal lobular 63 atrophic gastritis 63 anterior uveitis 63 Trichophyton rubrum 63 nasopharyngeal carcinoma 63 malignant phenotype 63 leukoplakia 63 endometrioid 63 lobule 63 renal fibrosis 63 astrocytoma 63 squamous cell 63 lymphoblasts 63 urothelial cancer 63 metastatic colorectal 63 advanced adenoma 63 keloid 63 calculi 63 gastrointestinal cancers 63 Glioblastoma Multiforme GBM 63 gene rearrangements 63 pericardial effusion 63 herpesviruses 63 nutlin 3a 63 endometrial 63 surgically resectable 63 teratoma 63 necrotizing 63 transitional cell carcinoma 63 subependymal giant cell 63 grade cervical intraepithelial 63 hepatocellular carcinoma 63 CP CPPS 63 amyloid deposition 63 submandibular gland 63 fallopian tube cancers 63 lung fibroblasts 63 LHRH receptor positive 63 chlamydial 63 bone metastasis 63 androgen deprivation 63 tumorigenicity 63 squamous 63 carcinoid tumors 63 castrate resistant 63 grade gliomas 63 colorectal polyps 63 pulmonary metastasis 63 Raf MEK ERK 63 cutaneous melanoma 63 WT1 63 pancreatic endocrine 63 JAK2 enzyme 63 basal cell cancers 63 metastatic malignant 63 chromosomal aberrations 63 prostate cancer metastases 63 HER2 expression 63 pancreatic lung 63 proliferative diabetic retinopathy 63 neuroblastomas 63 essential thrombocythemia 63 pathologic diagnosis 63 UVB induced 63 lymph node metastasis 63 esophageal cancers 63 polycythemia vera PV 63 node metastases 63 morphologic 63 lymphoid 63 hypothalamic pituitary 63 Cryptococcus neoformans 63 lymphangiogenesis 63 rebleeding 63 Uterine fibroids 63 mesothelial cells 63 neovascularization 63 abnormal pap smears 63 benign growths 62 myeloperoxidase 62 meningeal 62 lymphocytic 62 endotoxemia 62 seminoma 62 etiologic 62 fibrocystic changes 62 beta1 integrin 62 airway hyperresponsiveness 62 lobular 62 untreated celiac disease 62 TTR amyloidosis 62 granulomas 62 Hashimoto thyroiditis 62 testicular cancers 62 hepatoma 62 BRAF gene 62 ductal cancer 62 NSCLC tumors 62 epithelial tissues 62 xenograft tumors 62 HGPIN 62 haematologic 62 precancerous tumors 62 MMP inhibitors 62 situ CIS 62 Leukemias 62 nodular 62 myeloproliferative diseases 62 Gleevec resistant 62 thyrotoxicosis 62 systemic amyloidosis 62 colonic polyps 62 poorer prognosis 62 cirrhosis liver failure 62 squamous carcinoma 62 apoptotic pathway 62 CLL cells 62 colorectal polyp 62 esophagogastric junction 62 dysplastic lesions 62 hematopoietic cancers 62 adrenocortical cancer 62 malignant lesions 62 brain lesions 62 neurological manifestations 62 neuroendocrine cancers 62 osteoid osteoma 62 lymphoid organs 62 immunopathology 62 polyps growths 62 hypercalcemia 62 familial adenomatous polyposis 62 unknown etiology 62 keratoses 62 hypervascular tumors 62 EGFR mutant 62 epithelia 62 benign noncancerous 62 sclerosing 62 nonalcoholic steatohepatitis 62 superficial basal cell carcinoma 62 GIST tumors 62 intestinal polyps 62 renal tumors 62 Endometrial 62 BRAF mutation 62 pre malignant lesions 62 malignant lymphoma 62 fibroma 62 adrenocortical 62 plasma kallikrein 62 CMV infection 62 nodular melanoma 62 methicillin susceptible Staphylococcus aureus 62 supratentorial 62 hyperplastic polyps 62 colorectal adenocarcinoma 62 acute aortic dissection 62 pre cancerous growths 62 diabetic retinopathy DR 62 cirrhotic liver 62 Epstein Barr virus EBV 62 nonsmall cell lung cancer 62 candidiasis 62 differentiated thyroid 62 BRAF protein 62 malignant nodules 62 chromosomal rearrangement 62 miRNA expression 62 prostate cancers 62 submandibular 62 cerebral vasospasm 62 fungoides 62 vasculopathy 62 neuronal dysfunction 62 bowel cancers 62 unresectable tumors 62 metastatic bladder 62 leukaemias 62 intestinal epithelium 62 V#F mutation 62 sonographic diagnosis 62 primary cilia 62 bronchopulmonary dysplasia 62 downregulating 62 prostatic 62 mtDNA mutations 62 leukaemic stem cells 62 treat benign prostatic 62 MAPK pathway 62 lung tumors 62 JAK2 mutation 62 distant metastases 62 Squamous cell carcinomas 62 immunocompetent 62 somatic mutation 62 anal canal 62 acute leukemias 62 Carcinoid tumors 62 syngeneic 62 vulvar intraepithelial neoplasia 62 lactate dehydrogenase 62 Histologically 62 malignant neoplasms 62 inverse agonist 62 cardiac fibrosis 62 mosaicism 62 Nasal polyps 62 tumors GIST 62 mammary tumors 62 cutaneous lesions 62 Barrett mucosa 62 CTEPH 62 retinal ischemia 62 sonographic appearance 62 immunohistochemical 62 mitomycin C 62 cystic fibrosis chronic pancreatitis 62 axilla 62 Endometrial cancer 62 recurrent ovarian 62 chemosensitivity 62 breast endometrial 62 primary hyperparathyroidism 62 thyroid nodule 62 Six3 62 fibrotic disease 62 uterine cervix 62 bronchoalveolar 62 precancers 62 oesophageal 62 CMV infections 62 micrometastasis 61 cystic lesions 61 invasive lobular 61 tumor recurrence 61 mitogen activated protein kinases 61 nonmalignant 61 cholelithiasis 61 Immunohistochemical analysis 61 malignant neoplasm 61 B7 H3 61 Kaposi sarcoma 61 β catenin 61 ovarian breast 61 papular 61 squamous cell carcinomas 61 histone deacetylases 61 virulence genes 61 fibrocystic 61 keloid scarring 61 mesangial 61 adipogenic 61 tryptase 61 malignant polyps 61 tumor subtypes 61 uvea 61 contralateral breast 61 chronic periodontitis 61 presymptomatic 61 CD#c 61 LRP5 61 Metastases 61 osteolytic 61 astrocytomas 61 goblet cells 61 thrombocytosis 61 metastases 61 radioiodine therapy 61 node metastasis 61 melanocytic nevi 61 cytolytic 61 MTHFR 61 basal cell skin 61 glomerular 61 choroidal 61 bladder tumors 61 ovarian lung 61 hypervascular 61 lymphomas leukemias 61 leukoencephalopathy 61 leukemia AML 61 chemoresistant 61 dilated veins 61 Peutz Jeghers syndrome 61 Ribavirin causes 61 Smad3 61 Actinic Keratosis 61 desmoplastic 61 arterial calcification 61 neutrophilic 61 leukemic cell 61 neuroendocrine carcinoma 61 oropharyngeal cancer 61 NFkB 61 aminotransferases 61 torsade de pointes 61 fulminant hepatic failure 61 intracranial tumors 61 Trichomonas vaginalis 61 pancreatic cancers 61 interstitium 61 lymphoproliferative disorder 61 melanocyte 61 NKX2 61 activating mutations 61 malignant tissue 61 ALI ARDS 61 myomas 61 basal cell 61 thrombotic complications 61 medically inoperable 61 SGPT 61 NOTCH1 61 ALA PDT 61 axillary lymph nodes 61 lung fibrosis 61 thyrotropin 61 cardiac troponin 61 tumors 61 orchitis 61 aerodigestive tract 61 onset diabetes mellitus 61 nonalcoholic steatohepatitis NASH 61 bronchoalveolar lavage 61 corticosteroid therapy 61 colon carcinoma 61 p# activation 61 curative resection 61 prognostic significance 61 IL 1ß 61 myopathies 61 FGFs 61 osteoblastic 61 telomerase inhibition 61 BRCA1 mutations 61 Glioblastoma multiforme GBM 61 hepatocellular carcinoma HCC 61 microglial 61 pretransplant 61 Synovial sarcoma 61 Barrett esophagus 61 pathologic 61 EGF receptors 61 promoter methylation 61 proliferative disorders 61 COX2 61 extrahepatic 61 prognostic marker 61 GSTP1 61 ectoderm 61 spongiform encephalopathies 61 perianal 61 Endothelial 61 noncancerous tumors 61 prostate epithelial cells 61 pre cancerous actinic 61 alkaline phosphatase ALP 61 induce apoptosis 61 ABCB1 61 pneumococci 61 thromboembolic disease 61 mutated K ras 61 anti angiogenic agents 61 pT2 61 hepatorenal syndrome 61 grade squamous intraepithelial 61 PCa 61 hypertrophic scarring 61 HER2 overexpression 61 dedifferentiation 61 granulosa cell 61 neoadjuvant therapy 61 erythema nodosum 61 CIN3 61 anal lesions 61 metastatic relapsed 61 mesenteric 61 steatohepatitis 61 inhaled anesthetics 61 leukocyte adhesion 61 HER2 positive cancers 61 Neisseria gonorrhoeae 61 alveolar epithelial cells 61 pre cancerous polyps 61 EGFR inhibitors 61 noncancerous cells 61 TNF blocker therapy 61 intimal hyperplasia 61 PrPSc 61 biliary tract cancer 61 lysophosphatidic acid 61 HepG2 cells 61 amyloid deposits 61 embryonal 61 small lymphocytic lymphoma 61 breast cancer metastasis 61 Epstein Barr Virus EBV 61 inducible nitric oxide synthase 61 periodontitis 61 cAMP signaling 61 hypertrophic scars 61 mitochondrial mutations 61 leukocytosis 61 urethral stricture 61 pancreatic carcinoma 61 urothelial bladder cancer 61 hypermethylation 61 penile cancers 61 DFMO 61 insulin secreting beta 61 bleomycin 61 prostate ovarian 61 hepato 61 histopathologic examination 61 adenomas 61 monoclonal gammopathy 61 stage IIIB 61 intracellular bacteria 61 detecting precancerous 61 esophageal squamous cell carcinoma 61 urogenital tract 61 juvenile idiopathic arthritis 61 completely resected 61 hepatic steatosis 61 endocrine tumors 61 bladder ovarian 61 Basal cell carcinomas 61 fibrocytes 61 GBM tumors 61 adrenal cortex 61 elevated IOP 61 isoenzyme 61 gastric atrophy 61 hyperintense lesions 61 synovial cells 61 nonischemic 61 prostate pancreatic 61 carcinomatosis 60 lymphoid malignancies 60 HDAC2 60 lysosomal storage disease 60 lung pancreatic 60 IGF IR 60 nonvascular 60 impair fertility 60 Fibroid tumors 60 bone marrow suppression 60 Tumours 60 dilated cardiomyopathy DCM 60 renal pelvis 60 androgen independent 60 Cholangiocarcinoma 60 hedgehog signaling 60 oral squamous cell 60 amebiasis 60 Akt signaling 60 subclinical 60 basal cells 60 Acoustic neuromas 60 mRNA expression 60 neuritic 60 orthotopic 60 Carcinomas 60 histologies 60 aneurysm rupture 60 Pseudomonas aeruginosa infections 60 ischemic lesions 60 transurethral resection 60 exocrine 60 myxoma 60 cirrhotic 60 carcinoma HNSCC 60 hypoxia induced 60 familial ALS 60 autosomal dominant disorder 60 papillary RCC 60 gastroesophageal 60 hyperoxaluria 60 MYCN amplification 60 neuroinflammation 60 infantile hemangioma 60 Leydig cells 60 colony stimulating factors 60 SIADH 60 VEGF expression 60 extracapsular extension 60 mesothelium 60 clinically insignificant 60 pituitary adenoma 60 chemopreventive agent 60 prostate carcinogenesis 60 tonsillar 60 invasive carcinomas 60 hypoxemia 60 lymphatic tissue 60 endobronchial 60 hematopoietic cells 60 Clusterin 60 Prenatal diagnosis 60 Melanomas 60 P. gingivalis 60 thrombogenic 60 apoptosis induced 60 cranial irradiation 60 Surgical resection 60 TGF ß1 60 liver metastases 60 pancreatic islet cell 60 GSTT1 60 microglial activation 60 atrophic 60 nasopharyngeal cancer 60 Mycoplasma pneumoniae 60 HER2 amplification 60 inherited predisposition 60 multisystem disease 60 mutant p# 60 CHD7 60 hyperparathyroidism 60 gastrointestinal stromal tumor GIST 60 intracerebral 60 underarm lymph nodes 60 myxoid 60 IgA deficiency 60 idiopathic pulmonary 60 pre cancerous lesions 60 lung nodule 60 infarcts 60 Systemic lupus erythematosus 60 gastrointestinal stromal tumors GIST 60 p# mutation 60 systemic scleroderma 60 T1a 60 NKX#.# 60 activated lymphocytes 60 TGF b 60 autonomic dysfunction 60 necrotic core 60 radiosensitive 60 SUVmax 60 cytoreduction 60 microvascular disease 60 breast lesions 60 breast cancer subtypes 60 intestinal epithelial cells 60 SMAD4 60 fibrogenesis 60 hepatic metastases 60 hip osteonecrosis avascular 60 JAK STAT signaling 60 GRNCM1 60 Escherichia coli Klebsiella pneumoniae 60 SLNB 60 ERBB2 60 ovarian malignancy 60 endocervical 60 sentinel lymph node biopsy 60 cyclin E 60 hormone refractory 60 idiopathic myelofibrosis 60 radiochemotherapy 60 keloid scars 60 submucosal 60 egg follicles 60 bone morphogenic protein 60 peritoneal fluid 60 pyelonephritis 60 nonmetastatic 60 molecule epidermal 60 tumor histology 60 elastase 60 glandular tissue 60 mTOR inhibitors 60 myelodysplastic myeloproliferative diseases 60 hemorrhage necrosis 60 oncoproteins 60 Mitomycin C 60 lobular carcinomas 60 macrovascular complications 60 hepatocellular cancer 60 LRAT 60 germline mutations 60 acinar 60 serum prostate 60 multinucleated 60 radiosensitivity 60 tumor lysis syndrome 60 cardiac myocytes 60 RIP1 60 secretory pathway 60 genomic alterations 60 metabolic abnormalities 60 vascular endothelial 60 cellular prion protein 60 DNA methylation patterns 60 arrhythmogenic 60 primitive neuroectodermal tumor 60 predisposing factors 60 squamous cell cancer 60 prostate abnormalities 60 candida albicans 60 paragangliomas 60 EGFR mutation 60 proliferative retinopathy 60 P. acnes 60 infective endocarditis 60 KRAS mutation 60 BCR ABL mutations 60 anaplastic lymphoma kinase ALK 60 clinically detectable 60 PCNSL 60 HRCT 60 noninfectious 60 pulmonary hypertension PH 60 metastatic prostate 60 prion infection 60 cytoreductive surgery 60 progesterone receptor negative 60 TNFalpha 60 periventricular 60 baseline LDH 60 atherogenesis 60 liver scarring 60 Sertoli cell 60 umbilical vein 60 Rectal cancer 60 hormonally sensitive 60 colorectum 60 interstitial fibrosis 60 tau aggregates 60 metastatic uveal melanoma 60 castrate resistant prostate cancer 60 nephrogenic 60 melanoma tumors 60 lymphocytosis 60 FGFR3 60 colonic mucosa 60 thrombi 60 isotypes 60 Chronic lymphocytic leukemia CLL 60 murine model 60 EGFR HER2 60 urethritis 60 cardiac dysfunction 60 axonal degeneration 60 trans retinoic acid 60 C. pneumoniae 60 taxane resistant 60 Intussusception 60 hedgehog pathway 60 intraepithelial neoplasia 60 teratogens 60 pT3 60 post transplant lymphoproliferative 60 squamous cells 60 senescent cells 60 hepatic fibrosis 60 catheter angiography 60 hyperkeratosis 60 inflammatory cytokine 60 spontaneous regression 60 oropharyngeal 60 nodal metastases 60 polymorphonuclear 60 lymph node metastases 60 immunohistochemical staining 60 lymph node dissection 60 extracranial 60 bacterial colonization 60 Brain metastases 60 prostate TURP 60 PTEN protein 60 PSADT 60 potent inducer 60 myofibroblasts 60 p#INK#a 60 survivin expression 60 prostate cancer CRPC 60 hemorrhagic complications 60 benign biliary strictures 60 Polycythemia vera 60 tumor suppressor protein 60 allergic inflammation 60 Erythropoietic therapies may 60 fallopian tube carcinoma 60 anogenital warts 60 cancerous enlargement 60 malignancy 60 extramedullary 60 imatinib Gleevec 60 mammary cells 60 Radiofrequency ablation 60 seborrheic keratoses 60 H#K# [001] 60 Squamous Cell Carcinoma 60 immunoreactivity 60 bilateral oophorectomy 60 arterial thrombosis 60 dystrophies 60 FGFR2 60 Helicobacter pylori infection 60 embryonic tissues 60 TGF β 60 signaling cascades 60 Activating mutations 60 bronchial epithelial cells 60 perivascular 60 schwannomas 60 CIN2 + 60 MCF7 60 papilloma 60 hypercoagulable 60 antiproliferative effects 60 missense mutations 60 VEGF inhibitors 60 gastrointestinal mucositis 60 ALND 60 Treg cell 60 lung nodules 60 pancreatic ovarian 60 acute myelogenous leukemia AML 59 lymphocytic leukemia 59 postoperative pathology 59 needle aspiration 59 PIK3CA 59 glial tumors 59 Cytotoxic T 59 lung adenocarcinoma 59 beta catenin protein 59 Heavy menstrual bleeding 59 radical nephrectomy 59 pCR 59 chronic thromboembolic pulmonary 59 TET2 59 lymphoid cells 59 microvessel 59 Src kinase 59 sentinel lymph nodes 59 coagulopathy 59 myoclonus 59 choroidal melanoma